{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:42:25Z","timestamp":1790037745649,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003382","name":"Core Research for Evolutional Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001863","name":"New Energy and Industrial Technology Development Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001863","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.dmpk.2019.02.004","type":"journal-article","created":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T02:03:39Z","timestamp":1552097019000},"page":"293-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Quantitative investigation of hepatobiliary transport of [11C]telmisartan in humans by PET imaging"],"prefix":"10.1016","volume":"34","author":[{"given":"Kazuya","family":"Maeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Ikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Aita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyoshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kusuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Senda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12 Pt 1","key":"10.1016\/j.dmpk.2019.02.004_bib1","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1177\/009127000004001202","article-title":"Absorption, metabolism, and excretion of intravenously and orally administered [14C]telmisartan in healthy volunteers","volume":"40","author":"Stangier","year":"2000","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.dmpk.2019.02.004_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1527-3466.2000.tb00039.x","article-title":"A\u00a0review on telmisartan: a novel, long-acting angiotensin II-receptor antagonist","volume":"18","author":"Wienen","year":"2000","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.dmpk.2019.02.004_bib3","unstructured":"Interview form of Micardis\u00ae Tablets (drug information document written in Japanese; Boeringer Ingelheim)."},{"issue":"7","key":"10.1016\/j.dmpk.2019.02.004_bib4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1124\/dmd.105.009175","article-title":"Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans","volume":"34","author":"Ishiguro","year":"2006","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.dmpk.2019.02.004_bib5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/FPC.0b013e3283482502","article-title":"The impact of pharmacogenetics of metabolic enzymes and transporters on the pharmacokinetics of telmisartan in healthy volunteers","volume":"21","author":"Yamada","year":"2011","journal-title":"Pharmacogenetics Genom"},{"issue":"4","key":"10.1016\/j.dmpk.2019.02.004_bib6","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1124\/dmd.107.018903","article-title":"Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide","volume":"36","author":"Ishiguro","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.dmpk.2019.02.004_bib7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1017\/S1461145705006103","article-title":"The antipsychotic sultopride is overdosed--a PET study of drug-induced receptor occupancy in comparison with sulpiride","volume":"9","author":"Takano","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"issue":"8","key":"10.1016\/j.dmpk.2019.02.004_bib8","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1021\/mp500027c","article-title":"PET imaging of Oatp-mediated hepatobiliary transport of [(11)C] rosuvastatin in the rat","volume":"11","author":"He","year":"2014","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/j.dmpk.2019.02.004_bib9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1124\/dmd.118.080408","article-title":"A\u00a0clinical quantitative evaluation of hepatobiliary transport of [(11)C]dehydropravastatin in humans using positron emission tomography","volume":"46","author":"Kaneko","year":"2018","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmpk.2019.02.004_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/jpet.113.206425","article-title":"Evaluation of Oatp and Mrp2 activities in hepatobiliary excretion using newly developed positron emission tomography tracer [11C]dehydropravastatin in rats","volume":"347","author":"Shingaki","year":"2013","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.dmpk.2019.02.004_bib11","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1021\/mp200160t","article-title":"The involvement of organic anion transporting polypeptide in the hepatic uptake of telmisartan in rats: PET studies with [(1)(1)C]telmisartan","volume":"8","author":"Takashima","year":"2011","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/j.dmpk.2019.02.004_bib12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2967\/jnumed.111.098681","article-title":"PET imaging-based evaluation of hepatobiliary transport in humans with (15R)-11C-TIC-Me","volume":"53","author":"Takashima","year":"2012","journal-title":"J\u00a0Nucl Med"},{"issue":"2","key":"10.1016\/j.dmpk.2019.02.004_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/jpet.110.170092","article-title":"Positron emission tomography studies using (15R)-16-m-[11C]tolyl-17,18,19,20-tetranorisocarbacyclin methyl ester for the evaluation of hepatobiliary transport","volume":"335","author":"Takashima","year":"2010","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.dmpk.2019.02.004_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12149-011-0466-2","article-title":"First automatic radiosynthesis of 11C labeled Telmisartan using a multipurpose synthesizer for clinical research use","volume":"25","author":"Iimori","year":"2011","journal-title":"Ann Nucl Med"},{"issue":"6","key":"10.1016\/j.dmpk.2019.02.004_bib15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.nucmedbio.2012.01.008","article-title":"Whole-body distribution and radiation dosimetry of [11C]telmisartan as a biomarker for hepatic organic anion transporting polypeptide (OATP) 1B3","volume":"39","author":"Shimizu","year":"2012","journal-title":"Nucl Med Biol"},{"issue":"1","key":"10.1016\/j.dmpk.2019.02.004_bib16","first-page":"83","article-title":"Performance characteristics of a new 3-dimensional continuous-emission and spiral-transmission high-sensitivity and high-resolution PET camera evaluated with the NEMA NU 2-2001 standard","volume":"47","author":"Matsumoto","year":"2006","journal-title":"J\u00a0Nucl Med"},{"issue":"2","key":"10.1016\/j.dmpk.2019.02.004_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/dmd.109.030254","article-title":"Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans","volume":"38","author":"Watanabe","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.dmpk.2019.02.004_bib18","first-page":"149","article-title":"Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients","volume":"28","author":"Stangier","year":"2000","journal-title":"J\u00a0Int Med Res"},{"issue":"2","key":"10.1016\/j.dmpk.2019.02.004_bib19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1124\/dmd.112.049312","article-title":"Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement","volume":"41","author":"Grime","year":"2013","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.dmpk.2019.02.004_bib20","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1124\/dmd.116.074823","article-title":"Comparison of methods for estimating unbound intracellular-to-medium concentration ratios in rat and human hepatocytes using statins","volume":"45","author":"Yoshikado","year":"2017","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436718301526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436718301526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:54:25Z","timestamp":1761162865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436718301526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1347436718301526"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2019.02.004","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative investigation of hepatobiliary transport of [11C]telmisartan in humans by PET imaging","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2019.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}